Key facts
- This page summarizes Frederick J. Lynch's Form 4 filing for H-CYTE, INC..
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 23 Mar 2022, 08:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Exercise of in-the-money or at-the-money derivative security
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Exercise of in-the-money or at-the-money derivative security
Other
Additional SEC filing notes
Footnote F1
Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
Footnote F2
Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
Footnote F3
Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants.